Jessica T Markowitz1, Lisa K Volkening2, Lori M B Laffel2. 1. Pediatric, Adolescent, and Young Adult Section, and the Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA. Electronic address: jessica.markowitz@joslin.harvard.edu. 2. Pediatric, Adolescent, and Young Adult Section, and the Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, MA.
Abstract
OBJECTIVE: To examine care utilization, family attendance, and hemoglobin A1c levels in a multidisciplinary pediatric diabetes clinic. STUDY DESIGN: This retrospective electronic record review of deidentified data included patients (99% with type 1 diabetes) with established diabetes care, aged <30 years (mean age, 15 ± 5.2 years), and duration of diabetes >1 year (mean 8.5 ± 5.1 years) at first visit during a 2-year period. Outcomes included care utilization, family attendance, and glycemic control, as indicated by hemoglobin A1c level. Analyses included t tests, ANOVA, χ2 tests, ORs and 95% CIs, and multivariate analyses. RESULTS: The study cohort comprised 1771 patients, with a mean of 5.8 ± 2.8 visits per patient. Roughly 15% of the scheduled appointments resulted in a cancellation or no-show; 61% of patients missed ≥1 visit. Patients with ≥2 missed appointments had higher A1c values and were older than those with <2 missed visits. Almost one-half of visits were attended by mothers alone; fathers attended 22% of visits. Patients whose fathers attended ≥1 visit had lower A1c values than patients whose fathers never attended. Eighteen percent of patients had onsite mental health visits. Patients with ≥1 mental health visit had higher mean A1c values, shorter duration of diabetes, and were younger compared with those with no mental health visits. CONCLUSION: Our observations suggest the need to encourage attendance at diabetes visits and to include fathers to improve A1c values. The high rate of missed visits, especially in patients with poor glycemic control, identifies wasted provider effort when late cancellations/no-shows result in vacant clinic time. It is important to explore reasons for missed visits and to identify approaches to maximizing attendance, such as extended evening/weekend clinic hours and virtual visits.
OBJECTIVE: To examine care utilization, family attendance, and hemoglobin A1c levels in a multidisciplinary pediatric diabetes clinic. STUDY DESIGN: This retrospective electronic record review of deidentified data included patients (99% with type 1 diabetes) with established diabetes care, aged <30 years (mean age, 15 ± 5.2 years), and duration of diabetes >1 year (mean 8.5 ± 5.1 years) at first visit during a 2-year period. Outcomes included care utilization, family attendance, and glycemic control, as indicated by hemoglobin A1c level. Analyses included t tests, ANOVA, χ2 tests, ORs and 95% CIs, and multivariate analyses. RESULTS: The study cohort comprised 1771 patients, with a mean of 5.8 ± 2.8 visits per patient. Roughly 15% of the scheduled appointments resulted in a cancellation or no-show; 61% of patients missed ≥1 visit. Patients with ≥2 missed appointments had higher A1c values and were older than those with <2 missed visits. Almost one-half of visits were attended by mothers alone; fathers attended 22% of visits. Patients whose fathers attended ≥1 visit had lower A1c values than patients whose fathers never attended. Eighteen percent of patients had onsite mental health visits. Patients with ≥1 mental health visit had higher mean A1c values, shorter duration of diabetes, and were younger compared with those with no mental health visits. CONCLUSION: Our observations suggest the need to encourage attendance at diabetes visits and to include fathers to improve A1c values. The high rate of missed visits, especially in patients with poor glycemic control, identifies wasted provider effort when late cancellations/no-shows result in vacant clinic time. It is important to explore reasons for missed visits and to identify approaches to maximizing attendance, such as extended evening/weekend clinic hours and virtual visits.
Authors: Janet Silverstein; Georgeanna Klingensmith; Kenneth Copeland; Leslie Plotnick; Francine Kaufman; Lori Laffel; Larry Deeb; Margaret Grey; Barbara Anderson; Lea Ann Holzmeister; Nathaniel Clark Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Anthony A Hains; Kristoffer S Berlin; W Hobart Davies; Elaine A Parton; Ramin Alemzadeh Journal: Diabetes Care Date: 2006-04 Impact factor: 19.112
Authors: Elaine C Moreland; Alison Tovar; Jessica B Zuehlke; Deborah A Butler; Kerry Milaszewski; Lori M B Laffel Journal: J Pediatr Endocrinol Metab Date: 2004-11 Impact factor: 1.634
Authors: David J Wallace; Kristin N Ray; Abbye Degan; Kristen Kurland; Derek C Angus; Ana Malinow Journal: BMJ Qual Saf Date: 2017-11-24 Impact factor: 7.035
Authors: Stephanie S Crossen; James P Marcin; Lihong Qi; Hadley S Sauers-Ford; Allison M Reggiardo; Shelby T Chen; Victoria A Tran; Nicole S Glaser Journal: Diabetes Technol Ther Date: 2019-09-18 Impact factor: 6.118
Authors: Revital Nimri; Tadej Battelino; Lori M Laffel; Robert H Slover; Desmond Schatz; Stuart A Weinzimer; Klemen Dovc; Thomas Danne; Moshe Phillip Journal: Nat Med Date: 2020-09-09 Impact factor: 53.440
Authors: Rebecca Ortiz La Banca; Deborah A Butler; Lisa K Volkening; Lori M Laffel Journal: J Pediatr Health Care Date: 2020-04-03 Impact factor: 1.812